Free US stock ESG scoring and sustainability analysis for responsible investing considerations. We evaluate environmental, social, and governance factors that increasingly impact long-term company performance.
Celldex Therapeutics Inc. (CLDX) is trading at $31.35 as of 2026-04-07, posting a modest 0.06% dip in today’s session amid flat broader market trading for healthcare stocks. This analysis outlines key technical levels, prevailing market context, and potential short-term price scenarios for the clinical-stage biotech stock, with no recent earnings data available for the company as of publication. There are no confirmed, publicly disclosed pipeline or regulatory events scheduled for the near term
What are analysts saying about Celldex (CLDX) Stock | Price at $31.35, Down 0.06% - Open Stock Picks
CLDX - Stock Analysis
3188 Comments
640 Likes
1
Chrishawn
Senior Contributor
2 hours ago
Looking for like-minded people here.
👍 79
Reply
2
Feyre
Senior Contributor
5 hours ago
Really could’ve benefited from this.
👍 265
Reply
3
Terree
Registered User
1 day ago
This feels like a message for someone else.
👍 33
Reply
4
Sahal
Senior Contributor
1 day ago
I don’t know what this is, but it matters.
👍 93
Reply
5
Andy
Returning User
2 days ago
Volume is concentrated in certain sectors, reflecting shifting investor priorities.
👍 84
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.